
New Amsterdam Genomics — Comprehensive Preventive Genomic Analysis
New Amsterdam Genomics provides advanced whole-genome analysis designed to identify inherited risk factors for cardiovascular disease, cancer, metabolic disorders, and other complex conditions. Unlike limited genetic panels, this testing evaluates a broad range of clinically actionable variants to better understand long-term health risk and prevention opportunities.
Results are reviewed during a dedicated consultation that includes a PhD-level geneticist and Dr. Ryan Ince, allowing for detailed interpretation, risk clarification, and development of a personalized prevention strategy.
The total cost for testing and consultation is $4,000.
This service is designed for individuals seeking a deeper understanding of their genetic blueprint and a proactive, data-driven approach to long-term health planning.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.